What does CUSIP 74587V107 represent in this 13F holders report?

CUSIP 74587V107 is the security identifier for PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock in Q2 2015?

193 institutional investors reported PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock for Q2 2015. Use the holders table for investor-level position and value details.

PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI)

CUSIP: 74587V107

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class: Equity / Common Stock
Shares outstanding: 49,633,071
Total 13F shares: 30,442,694
Share change: +1,322,095
Total reported value: $3,553,611,040
Put/Call ratio: 90%
Price per share: $116.75
Number of holders: 193
Value change: -$40,063,235
Number of buys: 124
Number of sells: 107

Quarterly Holders Quick Answers

What is CUSIP 74587V107?
CUSIP 74587V107 identifies PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2015
Previous quarter: Q1 2015

Recent filing periods for CUSIP 74587V107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	11%	5,686,668	$1,342,679,000	—	31 Mar 2015	13F
FMR LLC	13F	Company	8.1%	4,025,798	$950,532,000	—	31 Mar 2015	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	6%	2,998,090	$707,879,000	—	31 Mar 2015	13F
Capital Research Global Investors	13F	Company	4.1%	2,040,740	$481,839,000	—	31 Mar 2015	13F
VANGUARD GROUP INC	13F	Company	3.3%	1,659,598	$391,847,000	—	31 Mar 2015	13F
FRANKLIN RESOURCES INC	13F	Company	2.1%	1,066,904	$251,905,000	—	31 Mar 2015	13F
BlackRock Fund Advisors	13F	Company	1.3%	649,940	$153,457,000	—	31 Mar 2015	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	1.2%	585,884	$138,334,000	—	31 Mar 2015	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	1.1%	568,529	$134,235,000	—	31 Mar 2015	13F
JANUS HENDERSON INVESTORS US LLC	13F	Company	1.1%	549,150	$129,660,000	—	31 Mar 2015	13F
BB BIOTECH AG	13F	Company	1.1%	521,991	$123,247,000	—	31 Mar 2015	13F
STATE STREET CORP	13F	Company	1%	518,268	$122,367,000	—	31 Mar 2015	13F
Capital International Investors	13F	Company	1%	503,700	$118,929,000	—	31 Mar 2015	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.91%	451,053	$106,498,000	—	31 Mar 2015	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	0.86%	425,579	$100,483,458	—	31 Mar 2015	13F
ORBIMED ADVISORS LLC	13F	Company	0.75%	370,200	$87,408,000	—	31 Mar 2015	13F
NORTHERN TRUST CORP	13F	Company	0.53%	262,042	$61,871,000	—	31 Mar 2015	13F
JPMORGAN CHASE & CO	13F	Company	0.46%	229,436	$54,172,000	—	31 Mar 2015	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.45%	222,100	$52,440,000	—	31 Mar 2015	13F
CAPITAL GUARDIAN TRUST CO	13F	Company	0.41%	204,620	$48,313,000	—	31 Mar 2015	13F
COLUMBUS CIRCLE INVESTORS	13F	Company	0.41%	203,011	$47,933,000	—	31 Mar 2015	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.39%	196,035	$46,285,000	—	31 Mar 2015	13F
NORGES BANK	13F	Company	0.37%	182,112	$42,998,000	—	31 Mar 2015	13F
ORBIS HOLDINGS LTD	13F	Company	0.35%	174,266	$41,146,000	—	31 Mar 2015	13F
BLACKROCK ADVISORS LLC	13F	Company	0.35%	171,589	$40,514,000	—	31 Mar 2015	13F
Cormorant Asset Management, LP	13F	Company	0.34%	167,300	$39,501,000	—	31 Mar 2015	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.33%	165,100	$38,982,000	—	31 Mar 2015	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.33%	164,852	$38,923,000	—	31 Mar 2015	13F
LORD, ABBETT & CO. LLC	13F	Company	0.3%	150,259	$35,478,000	—	31 Mar 2015	13F
WEATHERBIE CAPITAL, LLC	13F	Company	0.29%	144,721	$34,170,000	—	31 Mar 2015	13F
Bank of New York Mellon Corp	13F	Company	0.27%	134,677	$31,799,000	—	31 Mar 2015	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.27%	134,628	$31,787,000	—	31 Mar 2015	13F
FEDERATED HERMES, INC.	13F	Company	0.27%	132,393	$31,260,000	—	31 Mar 2015	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	0.25%	121,624	$28,717,000	—	31 Mar 2015	13F
UBS Group AG	13F	Company	0.24%	120,078	$28,351,000	—	31 Mar 2015	13F
DEUTSCHE BANK AG\	13F	Company	0.24%	117,081	$27,643,000	—	31 Mar 2015	13F
Invesco Ltd.	13F	Company	0.22%	109,910	$25,951,000	—	31 Mar 2015	13F
CHARTWELL INVESTMENT PARTNERS, LLC	13F	Company	0.22%	107,254	$25,324,000	—	31 Mar 2015	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.21%	105,186	$24,835,000	—	31 Mar 2015	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	0.19%	94,166	$22,233,000	—	31 Mar 2015	13F
D. E. Shaw & Co., Inc.	13F	Company	0.18%	88,548	$20,907,000	—	31 Mar 2015	13F
OppenheimerFunds, Inc.	13F	Company	0.18%	87,500	$20,660,000	—	31 Mar 2015	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.17%	82,212	$19,411,000	—	31 Mar 2015	13F
TEACHERS ADVISORS, LLC	13F	Company	0.17%	81,965	$19,353,000	—	31 Mar 2015	13F
BlackRock Investment Management, LLC	13F	Company	0.15%	76,626	$18,092,000	—	31 Mar 2015	13F
CLOUGH CAPITAL PARTNERS L P	13F	Company	0.15%	75,286	$17,776,000	—	31 Mar 2015	13F
TD ASSET MANAGEMENT INC	13F	Company	0.15%	73,300	$17,307,000	—	31 Mar 2015	13F
TimesSquare Capital Management, LLC	13F	Company	0.15%	72,500	$17,118,000	—	31 Mar 2015	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.14%	71,038	$16,773,000	—	31 Mar 2015	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.14%	70,051	$16,540,000	—	31 Mar 2015	13F

Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q2 2015

As of 30 Jun 2015, PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) was held by 193 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,442,694 shares. The largest 10 holders included ADAGE CAPITAL PARTNERS GP LLC, FMR LLC, Capital Research Global Investors, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, Grantham, Mayo, Van Otterloo & Co. LLC, FRANKLIN RESOURCES INC, ORBIMED ADVISORS LLC, JANUS CAPITAL MANAGEMENT LLC, and Capital International Investors. This page lists 193 institutional shareholders reporting positions in this security for the Q2 2015 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2015 vs Q1 2015 Across Filers

Q1 2015 holders

194

Q2 2015 holders

193

Holder diff

-1

Investor	Q1 2015 Shares	Q2 2015 Shares	Share Diff	Share Chg %	Q1 2015 Value $	Q2 2015 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.